Director Ramiro G. Peru filed a Form 4 with the SEC on November 20, 2026, disclosing the purchase of 1,000 shares of Elevance Health, Inc. common stock on November 19, 2026.
Key Highlights
- Reporting person: Ramiro G. Peru, identified in the filing as a Director of Elevance Health, Inc. (NYSE:ELV).
- Transaction: Acquisition (transaction code P) of 1,000 shares of common stock on November 19, 2026.
- Weighted average price: $383.86 per share, reflecting multiple trades executed at prices ranging from $383.62 to $383.92.
- Post-transaction ownership: 11,908 shares of common stock held directly following the reported transaction.
- No derivative securities were reported in Table II of the filing.
Ramiro G. Peru's November 2026 Open-Market Purchase of Elevance Health Common Stock
According to the Form 4 filing, Ramiro G. Peru, a director of Elevance Health, Inc., acquired 1,000 shares of the company's common stock on November 19, 2026. The filing reports a weighted average purchase price of $383.86 per share. As disclosed in the filing's footnote, the transaction was executed in multiple trades at prices ranging from $383.62 to $383.92, and the reporting person undertakes to provide full information on the number of shares and individual prices upon request by the SEC staff, the issuer, or a security holder.
Following the reported acquisition, the filing states that Peru directly holds 11,908 shares of Elevance Health common stock. The shares are reported as directly owned. No derivative securities transactions were reported in Table II of the filing.
The Form 4 was signed by Kathleen S. Kiefer as attorney in fact on November 20, 2026, the same date it was filed with the SEC. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as that checkbox was not selected on the form.
What Was Disclosed
Elevance Health director Ramiro G. Peru reported a direct open-market purchase of 1,000 shares of common stock at a weighted average price of $383.86 on November 19, 2026, bringing his total direct beneficial ownership to 11,908 shares.




Please wait processing your request...